MIF (Macrophage Migration Inhibitory Factor) is a multifunctional cytokine that exhibits a wide range of biological activities beyond its original discovery as an inhibitor of macrophage migration. MIF is a key regulator of innate and adaptive immune responses. It promotes the release of pro-inflammatory cytokines like TNF-α, IL-1, IL-6, and IL-8, enhancing inflammation and recruiting immune cells to sites of injury or infection. However, MIF also plays a role in immune suppression, particularly in cancer, where it can inhibit the anti-tumor activity of macrophages and T cells. MIF promotes cell proliferation and survival through multiple mechanisms, including activation of the MAPK/ERK pathway, inhibition of p53-mediated apoptosis, and upregulation of anti-apoptotic proteins. These effects contribute to the growth and progression of various cancers. MIF is a critical regulator of glucose homeostasis, acting as a counter-regulatory hormone to insulin. It inhibits insulin-mediated glucose uptake in adipocytes and muscle cells, promoting hyperglycemia in response to stress or inflammation. This function of MIF has implications for the development of insulin resistance and type 2 diabetes. MIF is also involved in the regulation of pituitary hormone secretion, particularly prolactin and ACTH. It stimulates the release of these hormones, which can have wide-ranging effects on reproductive function, stress response, and metabolism.